Merck (MRK) Minority Interest (2009 - 2026)

Merck (MRK) has 18 years of Minority Interest data on file, last reported at $53.0 million in Q1 2026.

• Quarterly Minority Interest fell 18.46% year-over-year to $53.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.0 million (down 18.46% YoY) and the FY2025 annual result came in at $56.0 million, down 5.08% from the prior year.
• Minority Interest retreated to $53.0 million in Q1 2026 per MRK's latest filing, from $56.0 million in the prior quarter.
• Across five years, Minority Interest topped out at $75.0 million in Q2 2022 and bottomed at $49.0 million in Q2 2023.
• The 5-year median for Minority Interest is $60.0 million (2024), against an average of $61.6 million.
• The widest annual swing landed in 2023, when Minority Interest tumbled 34.67%; it then jumped 34.69% in 2024.
• Tracing MRK's Minority Interest over 5 years: stood at $67.0 million in 2022, then decreased by 19.4% to $54.0 million in 2023, then grew by 9.26% to $59.0 million in 2024, then decreased by 5.08% to $56.0 million in 2025, then decreased by 5.36% to $53.0 million in 2026.
• Per Business Quant, the three latest MRK Minority Interest figures stand at $53.0 million (Q1 2026), $56.0 million (Q4 2025), and $57.0 million (Q3 2025).

Peer Comparison